Stock-Based Compensation, Restricted Stock and Stock Options (Details) - Schedule of restricted stock awards - Restricted stock units [Member] - $ / shares |
3 Months Ended | 9 Months Ended |
---|---|---|
Mar. 31, 2022 |
Dec. 31, 2021 |
|
Stock-Based Compensation, Restricted Stock and Stock Options (Details) - Schedule of restricted stock awards [Line Items] | ||
Number of Shares, Beginning | 1,939,683 | 1,061,905 |
Weighted Average Grant-Date Fair Value, Beginning | $ 3.08 | $ 4.5 |
Number of Shares, Ending | 777,778 | 1,939,683 |
Weighted Average Grant-Date Fair Value, Ending | $ 1.37 | $ 3.08 |
Number of Shares, Granted | 33,332 | 1,200,000 |
Weighted Average Grant-Date Fair Value, Granted | $ 3.25 | $ 1.33 |
Number of Shares, Vested | (1,195,237) | (322,222) |
Weighted Average Grant-Date Fair Value, Vested | $ 4.2 | $ 1.24 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. No definition available.
|
X | ||||||||||
- Details
|